US-guided localization of non-palpable breast cancer and sentinel node using 99mtechnetium-albumin colloid;Localización ecodirigida del cáncer de mama no palpable y del ganglio centinela con 99mtecnecio-coloide de albúmina

Radiologia

Volumn 49, Issue 5, 2007, Pages 329-334

  Ricart Selma, Verónica ^a   Gonzalez Noguera P J ^a   Camps Herrero, J ^a   Martinez Rubio C ^a   Lloret Marti M T ^b   Torregrosa Andres A ^a  

^a HOSPITAL DE LA RIBERA   (Spain)

^b NONE

Author keywords

Breast; Non palpable; Occult lesion; Radio guided surgery; Sentinel node

Indexed keywords

NANOCOLL; NANOCOLL TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SURGERY; CARCINOMA IN SITU; CONTROLLED STUDY; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; SCINTIGRAPHY; SENTINEL LYMPH NODE BIOPSY;

EID: 35348973920     PISSN: 00338338     EISSN: 15781771     Source Type: Journal    
DOI: 10.1016/S0033-8338(07)73787-6     Document Type: Article

References (22)

1. Kerlikwske K, Smith-Bindman R, Ljung BM, Grady D. Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med. 2003;139:274-84.
2. Verkooijen HM, Peeters PH, Pijnappel RM, Koot VC, Schipper ME, Borel Rinkes IH. Diagnostic accuracy of needle-localized open breast biopsy for impalpable breast disease. Br J Surg. 2000;87:344-7.
3. Barros A, Cardoso MA, Sheng PY, Costa PA, Pelizon C. Radioguided localisation of non-palpable breast lesions and simultaneus sentinel lybph node mapping. Eur J Nucl Med Mol Imaging. 2002;29:1561-5.
4. Feggi L, Basaglia E, Corcione S, Querzoli P, Soliani G, Ascanelli S, et al. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localization. Eur J Nucl Med. 2001;28:1589-96.
5. Luini A, Zurrida S, Paganelli G, Galimberti V, Sacchini V, Monti S, et al. Comparison of radioguided excision with wire localization of occult breast lesions. Br J Surg. 1999;86:522-5.
6. Gennari R, Galimberti V, de Cicco C, Zurrida S, Zerwes F, Pigatto F, et al. Use of technetium-99m-labeled colloid albumin for preoperative and intraoperative localization of non-palpable breast lesions. J Am Coll Surg. 2000;190:692-9.
7. Paganelli G, Veronesi U. Innovation in early breast cancer surgery: radio-guided occult lesion localization and sentinel node biopsy. Nucl Med Comm. 2002;23:625-7.
8. Paganelli G, Luini A, Veroneri U. Radioguided occult lesion localization (ROLL) ion breast cancer: maximizing efficacy, minimizing mutilation. Ann Oncol. 2002;13:1839-40.
9. Luini A, Zurrida S, Galimberti V, Paganelli G. Radioguided surgery of occult breast lesions. Eur J Cancer. 1998;34:205-6.
10. Rönkä R, Kroderus L, Leppänen E, Bon Smitten K, Leidenius M. Radio-guided occult lesion localization in patients undergoing breast-conserving surgery and sentinel node biopsy. Am J Surg. 2004;187:491-7.
11. De Cicco C, Trifiro G, Intra M, Marotta G, Ciprian A, Frasion A, et al. Optimised nuclear medicine method for tumor marking and sentinel node detection in occult primary breast lesions. Eur J Med Mol Imaging. 2004;31:349-54.
12. Velanovich V, Lewis FR Jr, Nathanson SD, Strand VF, Talpos GB, Bhandarkar S, et al. Comparison of mammographically guided breast biopsy techniques. Ann Surg. 1999;229:625-30.
13. Chatwich DR, Shorthouse AJ. Wire-directed localisation biopsy of the breast: an audit of results and analysis of factors influencing therapeutic value in the treatment of breast cancer. Eur J Surg Oncol. 1997;23:128-33.
14. Kaufman CS, Jacobson L, Bachman B, Kaufman LB. Intraoperative ultrasonography guidance is accurate and efficient according to results in 100 breast cancer patients. Am J Surg. 2003;186:378-82.
15. Rubio IT, Henry-Tillman R, Klimberg VS. Uso quirúrgico del ultrasonido mamario. Clin Chir N Am. 2003:751-68.
16. Harlow SP, Krag DN, Ames SE, Weaver DL. Intraoperative ultrasound localisation to guided surgical excision of nonpalpable breast carcinoma. J Am Coll Surg. 1999;189:241-6.
17. Gray RJ, Guliano R, Dauway EL, Cox CE, Reintgen DS. Radioguidance for nonpalpable primary lesions and sentinel lynph node(s). Am J Surg. 2001;182:404-6.
18. Goal A, Newcombe RG, Mansel RE, on behalf of the ALMANAC Trialists Group. Sentinel lymph node biopsy in patients with multifocal breast cancer. EJSO. 2004;30:475-9.
19. Tanis PJ, Deurloo EE, Valdés Olmos RA, Rutgers EJ, Nieweg OE, Besnard AP, et al. Singel intralesional trazer dose for radioguided excision of clinically occult breast cancer and sentinel node. Ann Surg Oncol. 2001;8:850-5.
20. De Cicco C, Pizzamiglio M, Trifiro G, Luini A, Ferrari M, Prisco G, et al. Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Q J Nucl Med. 2002;46:145-51.
21. Rampaul RS, Dudley NJ, Thompson JZ, Burrell H, Evans AJ, Wilson RM, et al. Radioisotope for occult lesion localisation (ROLL) of the breast does not require extra radiator protection procedures. The Breast. 2003;12:150-2.
22. Rampaul RS, MacMillan RD, Evans AJ. Intraductal injection of the breast: a potential pitfall of radioisotope occult lesion localization. Br J Radiol. 2003;76:425-6.